(Q34589360)

English

The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

multiple sclerosis

0 references

0 references

0 references

cannabinoid receptor

0 references

Javier Palazuelos

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Raphael Mechoulam

6

object named as

Raphael Mechoulam

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Nathalie Davoust

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Boris Julien

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Eric Hatterer

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Tania Aguado

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Cristina Benito

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Augusto Silva

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Manuel Guzmán

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Serge Nataf

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Ismael Galve-Roperh

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

language of work or name

0 references

publication date

11 March 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Journal of Biological Chemistry

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

283

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

13320-13329

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

The molecular logic of endocannabinoid signalling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Emerging properties of cannabinoid medicines in management of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Cannabinoids control spasticity and tremor in a multiple sclerosis model

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Cannabinoids and neuroinflammation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Cannabinoid-based drugs as anti-inflammatory therapeutics

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Cannabinoid CB2 receptor: a new target for controlling neural cell survival?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Bone marrow CD34+/B220+ progenitors target the inflamed brain and display in vitro differentiation potential toward microglia.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Cannabinoid receptors as therapeutic targets.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Flt3+ macrophage precursors commit sequentially to osteoclasts, dendritic cells and microglia

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Expression of CCR2 in Both Resident and Bone Marrow-Derived Microglia Plays a Critical Role in Neuropathic Pain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34589360&oldid=1740037259"